To confirm that ACRJ-PC28 is a prostate cancer cell line, we first examined at the protein level, the presence of prostate specific biomarkers, AR, AMACR, NKX3.1, and PSA (Table 1). This evidence concerns the gene AMACR and prostate carcinoma.